Tandem Diabetes Care, Inc. (TNDM) Cash Flow Statement

The relationship between net income and operating cash flow is highly erratic, with working capital changes driving most of the quarter-to-quarter swings. In 2026Q2, a -$41.5M working capital outflow overwhelmed the -$21.2M net loss, while in 2026Q1 a +$3.7M working capital inflow helped produce positive OCF despite a net loss. This suggests that reported losses are not a reliable proxy for cash burn, and investors should focus on the underlying operational cash generation rather than quarterly OCF/NI ratios.

The FCF trajectory is deteriorating, with 2026Q2 marking a significant reversal from the +$4.8M and +$3.1M FCF in 2026Q1 and 2025Q4, respectively. The negative FCF is driven by a sharp working capital outflow rather than elevated capex, which remains modest at 1.6% of revenue. This suggests that the company's cash generation is highly sensitive to timing of collections and inventory, and the recent deterioration may indicate operational strain as the Mobi launch ramps.

Capex has remained consistently low, ranging from 1.1% to 2.9% of revenue, which suggests that the company is not investing heavily in fixed assets. This implies that the cash burn is driven by operating expenses and working capital dynamics rather than expansionary capital projects. The low capex may indicate that the company is relying on outsourced manufacturing or that the Mobi platform does not require significant new fixed investment, but it also means that any future growth will require working capital rather than capex.

The working capital volatility is the primary driver of cash flow variability, with 2026Q2 showing a -$41.5M outflow that dwarfs the net loss. This pattern suggests that the company is building inventory or extending receivables ahead of product transitions, particularly around the Mobi launch. The negative working capital changes in 2025Q4 and 2024Q4 also align with year-end inventory builds, indicating a seasonal pattern that investors should monitor for potential cash drag.

The absence of dividends and buybacks is consistent with a company in a cash preservation mode, given the negative net income and thin cash balance of $90.6M. The $43.5M acquisition in 2025Q1, likely related to Sugarmate, represents the only significant capital deployment, which may have been aimed at enhancing the data platform. This suggests that management is prioritizing operational investments over shareholder returns, but the lack of buybacks also means there is no cushion for the stock price if cash burn continues.